Integrin Distribution in Malignant Melanoma: Association of the β3 Subunit with Tumor Progression

Cancer Research

Volumn 50, Issue 20, 1990, Pages 6757-6764

  Albelda, Steven M ^a,b   Mette, Stephen A ^a,b   Elder, David E ^c,d   Stewart, RoseMary ^c   Damjanovich, Laszlo ^b   Herlyn, Meenhard ^b,c   Buck, Clayton A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTEGRIN;

ARTICLE; CELL CULTURE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; TUMOR GROWTH;

HUMAN; INTEGRINS; MELANOCYTES; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0025012050     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Liotta, L. A. Tumor invasion and metastases-role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res., 46: 1–7, 1986.
2. Juliano, R. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim. Biophys. Acta, 907: 261–278, 1987.
3. Ruoslahti, E., and Giancotti, F. G. Integrins and tumor cell dissemination. Cancer Cells, 7: 119–126, 1989.
4. Buck, C. A., and Horwitz, A. F. Cell surface receptors for extracellular matrix molecules. Annu. Rev. Cell Biol., 13: 179–205, 1987.
5. Hynes, R. O. Integrins: a family of cell surface receptors. Cell, 48: 549–554, 1987.
6. Ruoslahti, E., and Pierschbacher, M. D. New perspectives in cell adhesion: RGD and integrins. Science (Washington DC), 238: 491–497, 1987.
7. Albelda, S. M., and Buck, C. A. Integrins and other cell adhesion molecules. FASEB J., 4: 2868–2880, 1990.
8. Cheresh, D. A., and Spiro, R. C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J. Biol. Chem., 262: 17703–17711, 1987.
9. Lawler, J., Weinstein, R., and Hynes, R. O. Cell attachment to thrombospon-din: the role of ARG-GLY-ASP, calcium, and integrin receptors. J. Cell Biol., 707: 2351–2361, 1988.
10. Plantefaber, L. C., and Hynes, R. O. Changes in integrin receptors on oncogenically transformed cells. Cell, 56: 281–290, 1989.
11. Peltonen, J., Larjava, H., Jaakkola, S., Grainick, H., Akiyama, S. K., Yamada, S. S., Yamada, K. M., and Uitto, J. Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. J. Clin. Invest., 84: 1916–1923, 1989.
12. Dedhar, S., and Saulnier, R. Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptors. J. Cell Biol., 770: 481–489, 1990.
13. Akiyama, S. K., Larjava, H., and Yamada, K. M. Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells. Cancer Res., 50: 1601–1607, 1990.
14. Pierschbacher, M. D., and Ruoslahti, E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature (London), 309: 30–33, 1984.
15. Yamada, K. M., and Kennedy, D. W. Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can auto-inhibit fibronectin function. J. Cell Biol., 99: 29–36, 1984.
16. Gehlsen, K. R., Argraves, W. S., Pierschbacher, M. D., and Ruoslahti, E. Inhibition of tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J. Cell Biol., 106: 925–930, 1988.
17. Humphries, M. J., Olden, K., and Yamada, K. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science (Washington DC), 233: 467–470, 1986.
18. Saiki, I., Murata, J., Lida, J., Nishi, N., Sugimura, K., and Azuma, I. The inhibition of murine lung metastasis by synthetic polypeptides [poly(arg-gly-asp) and poly(tyr-ile-gly-ser-arg)] with a core sequence of cell adhesion molecules. Br. J. Cancer, 59: 194–197, 1988.
19. Humphries, M. J., Yamada, K. M., and Olden, K. Investigation of the biological effects of anti-cell adhesion synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. J. Clin. Invest., 81: 782–790, 1988.
20. Boukerche, H., Berthier-Vergnes, O., Bailly, M., Dore, J. F., Leung, L. K., and McGregor, J. L. A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein Ilb/IIIa complex inhibits human melanoma growth in vivo. Blood, 74: 909–912, 1989.
21. Giancotti, F. G., and Ruoslahti, E. Elevated levels of the a50i fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60: 849–859, 1990.
22. Clark, W., Elder, D., Guerry, D., Epstein, M., Greene, M., and VanHorn, M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol., 15: 1147–1165, 1984.
23. Clark, W., Elder, D., and VanHorn, M. The biologic forms of malignant melanoma. Hum. Pathol., 77: 443–452, 1986.
24. Herlyn, M., Thurin, J., Balaban, G., Bennicelli, J., Herlyn, D., Elder, D., Bondi, E., Guerry, D., Nowell, P., Clark, W., and Koprowski, H. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res., 45: 5670–5676, 1985.
25. Balaban, G., Herlyn, M., Clark, W., and Nowell, P. Karyotypic evolution in human malignant melanoma. Cancer Genet. Cytogenet., 19: 113–122, 1986.
26. Herlyn, M., Rodeck, U., Mancianti, M., Cardillo, F., Lang, A., Ross, A., Jambrosic, J., and Koprowski, H. Expression of melanoma–associated antigens in rapidly dividing human melanocytes in culture. Cancer Res., 47: 3057–3061, 1987.
27. Rodeck, U., Herlyn, M., Manssen, H., Furlanetto, R., and Koprowski, H. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int. J. Cancer, 40: 687–690, 1987.
28. Wayner, E., and Carter, W. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique α and β subunits. J. Cell Biol., 105: 1873–1884, 1987.
29. Wayner, E., Carter, W., Piotrowicz, R., and Kunicki, T. The functions of multiple extracellular matrix receptors in mediating cell adhesion to extra–cellular matrix: preparation of a monoclonal antibody to the fibronectin receptor that specifically inhibits adhesion to fibronectin and reacts with platelet glycoproteins Ic/Ha. J. Cell Biol., 107: 1881–1801, 1988.
30. Hemler, M., Huang, C., and Schwarz, L. The VLA protein family. J. Biol. Chem., 262: 3300–3309, 1987.
31. Hemler, M., Ware, C., and Strominger, J. Characterization of a novel differentiation antigen complex recognized by a monoclonal antibody (A1A5): unique activation-specific molecular forms on stimulated T cells. J. Immunol., 131: 334–340, 1983.
32. Sonnenberg, A., Modderman, P. W., and Hogervotst, F. Laminin receptor on platelets is the integrin VLA-6. Nature (London), 336: 487–489, 1988.
33. Brass, L., Shatil, S., Kunicki, T., and Bennett, J. Effect of calcium on the stability of the platelet membrane glycoprotein Hb/IIIa complex. J. Biol. Chem., 260: 7875–7881, 1985.
34. Cheresh, D., and Harper, J. Arg-Gly-Asp recognition by a cell adhesion receptor requires its 130 kDA a subunit. J. Biol. Chem., 262: 1434–1437, 1987.
35. Albelda, S. M., Daise, M., Levine, E. M., and Buck C. A. Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. J. Clin. Invest., 83: 1992–2002, 1989.
36. Elder, D., Guerry, D., Epstein, M., Zehngebot, C., Lusk, E., VanHorn, M., and Clark, W. Invasive malignant melanomas lacking competence for metastasis. Am. J. Dermatopathol., 6: 55–62, 1984.
37. Wayner, E. A., Garcia-Pardo, A., Humphries, M. J., McDonald, J. A., and Carter, W. G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-2) in plasma fibronectin. J. Cell Biol., 109: 1321–1330, 1989.
38. Elices, M. J. Osborn, L., Takada, Y., Crouse, C., Luhowskyl, S., Hemler, M., and Lobb, R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA/4/fibronectin binding site. Cell, 60: 577–584, 1990.
39. Rice, E. G., and Bevilacqua, M. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science (Washington DC), 246: 1303–1306, 1989.
40. Kramer, R., and Marks, N. Identification of integrin collagen receptors on human melanoma cells. J. Biol. Chem., 264: 4684–4688, 1989.
41. Mould, P. P., Wheldon, L. A., Komoriya, A., Wayner, E. A., Yamada, K. M., and Humphries, M. J. Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin atfi. J. Biol. Chem., 265: 4020–4024, 1990.
42. Ramos D. M., Berston, E. D., and Kramer, R. H. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. Cancer Res., 50: 728–734, 1990.
43. Elder, D., Rodeck, U., Thurin, J., Cardillo, F., Clark, W., Stewart, R., and Herlyn, M. Antigenic profile of tumor progression stages in melanocytic nevi and melanomas. Cancer Res., 49: 5091–5096, 1989.
44. Poste, G., and Greig, R. The experimental and clinical implications of cellular heterogeneity in malignant tumors. J. Cancer Res. Clin. Oncol., 106: 159–170., 1983.
45. Nicolson, G. L. Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metas. Rev., 3: 25–42, 1984.
46. McGregor, B., McGregor, J. L., Weiss, L. M., Wood, G. S., Hu, C-H., Boukerche, H. and Warnke, R. A. Presence of cytoadhesins (Hb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am. J. Clin. Pathol., 92: 495–499, 1989.
47. Clark, W., Elder, D., Guerry, D., Brahman, L., Trock, B., Schultz, D., Synnestvedt, M., and Halpern, A. Model predicting survival in stage 1 melanoma based on tumor progression. J. Natl. Cancer Inst., 81: 1893–1904, 1989.
48. Vogel, B., Tarone, G., Giancotti, F. G., Gailit, J., and Ruoslahti, E. A novel fibronectin receptor with an unexpected subunit composition (αν/β1). J. Biol. Chem., 265: 5934–5937, 1990.
49. Krissansen, G. W., Elliott, M. J., Lucas, C. M., Stomski, F. C., Berndt, M. C., Cheresh, D. A., Lopez, A. F., and Burns, G. F. Identification of a novel integrin β subunit expressed on cultured monocytes (macrophages). J. Biol. Chem., 265: 823–830, 1990.
50. Cheresh, D., Smith, J., Cooper, H., and Quaranta, V. A novel vitronectin receptor integrin (αvβx) is responsible for distinct adhesive properties of carcinoma cells. Cell, 57: 59–69, 1989.